Aspen Aerogels, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call
What Aspen Aerogels Bears Saw Before The Fall
Aspen Aerogels Q2 2026 Earnings Call Transcript
Aspen Aerogels (ASPN) Price Target Increased by 22.05% to 7.90
Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5
Aspen Aerogels: Green Shoots Fail To Truly Impress Investors
Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot
Aspen Aerogels (ASPN) Stock Sees Fair Value Lift After Q2 Improves Segment Visibility
Aspen Aerogels, Inc. 2026 Q2 - Results - Earnings Call Presentation
Aspen Aerogels Inc (ASPN) (Q2 2026) Earnings Call Highlights: Strong Q3 Outlook and European ...
Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript
Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates
Aspen Aerogels (NYSE:ASPN) Jumps on Q2 Revenue Beat and Raised Guidance
Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aspen Aerogels Sees Q3 GAAP EPS $(0.11)-$(0.07) vs $(0.14) Est; Sees Sales $65.000M-$80.000M vs $56.933M Est
Aspen Aerogels, Inc. to Present at the 29th Annual Oppenheimer Conference
Aspen Aerogels, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call
Beerenberg Prevails in Patent Case Against Aspen Aerogels
How The Aspen Aerogels (ASPN) Investment Story Is Shifting With Mixed Analyst Views
Aspen Aerogels Begins Staged Restart of East Providence Facility
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.